Marcel Mueller

Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors:  4-(Phenylamino)pyrazolo[3,4-<i>d</i>]pyrimidines

Peter Traxler, Guido Bold, Joerg Frei et al. · Journal of Medicinal Chemistry · 1997 · 205 citations · Full text

Egf-r Tyrosine Kinase, Pharmacotherapy, System Pharmacology +19

Low molecular weight, non-peptide fibrinogen receptor antagonists

Leo Alig, Albrecht Edenhofer, Paul Hadváry et al. · Journal of Medicinal Chemistry · 1992 · 192 citations

Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor.

Winfried S. Wels, Ina Maria Harwerth, Marcel Mueller et al. · PubMed · 1992 · 188 citations

Selective Inhibition, Tumor Cell Growth, Human Breast +14

CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.

Urs Regenass, Helmut Mett, J. Staněk et al. · PubMed · 1994 · 113 citations

Antitumor Activity, Whereas Spermidine, Pharmacotherapy +18

Dianilinophthalimides: Potent and Selective, ATP-Competitive Inhibitors of the EGF-Receptor Protein Tyrosine Kinase

Uwe Trinks, Elisabeth Buchdunger, Pascal Furet et al. · Journal of Medicinal Chemistry · 1994 · 90 citations · Full text

Medicinal Chemistry, Signal Transduction, Biochemistry +15